FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104593712> ?p ?o ?g. }

• W2104593712 endingPage "780" @default.
• W2104593712 startingPage "773" @default.
• W2104593712 abstract "Background.Target-controlled infusions (TCI) are used to simplify administration and increase precision of i.v. drugs during general anaesthesia. However, there is a limited relationship between preset targets and measured concentrations of drugs and between measured concentrations and measures of brain function, such as the bispectral index (BIS).Methods.We set out to evaluate the performance of TCI devices for propofol (Diprifusor®) and remifentanil (Remifusor, prototype), during laparoscopic cholecystectomy in 21 patients. We also checked if there was any correlation between serum concentrations of propofol and BIS during individually adjusted anaesthesia.Results.The Diprifusor and Remifusor had a median absolute performance error of 60% and 25% respectively. Propofol concentrations were underpredicted by a median of 60%, and remifentanil concentrations were slightly overpredicted by a median of 7%. When anaesthesia was adjusted to keep BIS values between 45 and 60, no correlation existed between measured concentrations of propofol and the corresponding BIS values, although both BIS and serum propofol concentration discriminated well between the awake and asleep states. Emergence was rapid and uneventful in all patients. Female patients had a more rapid emergence than male patients (6.6 and 11.6 min respectively).Conclusions.TCI devices for remifentanil and propofol result in large variation in measured serum concentrations. The lack of correlation between BIS and serum concentrations of propofol adds to the debate about whether BIS measures hypnosis as a graded state during surgery. This study confirms that women wake up faster than men, but provides no explanation for this repeatedly shown difference. Target-controlled infusions (TCI) are used to simplify administration and increase precision of i.v. drugs during general anaesthesia. However, there is a limited relationship between preset targets and measured concentrations of drugs and between measured concentrations and measures of brain function, such as the bispectral index (BIS). We set out to evaluate the performance of TCI devices for propofol (Diprifusor®) and remifentanil (Remifusor, prototype), during laparoscopic cholecystectomy in 21 patients. We also checked if there was any correlation between serum concentrations of propofol and BIS during individually adjusted anaesthesia. The Diprifusor and Remifusor had a median absolute performance error of 60% and 25% respectively. Propofol concentrations were underpredicted by a median of 60%, and remifentanil concentrations were slightly overpredicted by a median of 7%. When anaesthesia was adjusted to keep BIS values between 45 and 60, no correlation existed between measured concentrations of propofol and the corresponding BIS values, although both BIS and serum propofol concentration discriminated well between the awake and asleep states. Emergence was rapid and uneventful in all patients. Female patients had a more rapid emergence than male patients (6.6 and 11.6 min respectively). TCI devices for remifentanil and propofol result in large variation in measured serum concentrations. The lack of correlation between BIS and serum concentrations of propofol adds to the debate about whether BIS measures hypnosis as a graded state during surgery. This study confirms that women wake up faster than men, but provides no explanation for this repeatedly shown difference." @default.
• W2104593712 created "2016-06-24" @default.
• W2104593712 creator A5000460815 @default.
• W2104593712 creator A5006898867 @default.
• W2104593712 creator A5081779855 @default.
• W2104593712 creator A5085722983 @default.
• W2104593712 date "2003-12-01" @default.
• W2104593712 modified "2023-10-10" @default.
• W2104593712 title "Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery † †This article is accompanied by the Editorial." @default.
• W2104593712 cites W1493303551 @default.
• W2104593712 cites W1974231876 @default.
• W2104593712 cites W1980959248 @default.
• W2104593712 cites W1981742453 @default.
• W2104593712 cites W2017309204 @default.
• W2104593712 cites W2018329839 @default.
• W2104593712 cites W2024687868 @default.
• W2104593712 cites W2029494431 @default.
• W2104593712 cites W2041326817 @default.
• W2104593712 cites W2048373218 @default.
• W2104593712 cites W2049289092 @default.
• W2104593712 cites W2060357972 @default.
• W2104593712 cites W2062603017 @default.
• W2104593712 cites W2064676985 @default.
• W2104593712 cites W2072665752 @default.
• W2104593712 cites W2077030810 @default.
• W2104593712 cites W2120534719 @default.
• W2104593712 cites W2150641541 @default.
• W2104593712 cites W2159542589 @default.
• W2104593712 cites W2325059247 @default.
• W2104593712 cites W2935387765 @default.
• W2104593712 cites W4233837547 @default.
• W2104593712 doi "https://doi.org/10.1093/bja/aeg258" @default.
• W2104593712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14633743" @default.
• W2104593712 hasPublicationYear "2003" @default.
• W2104593712 type Work @default.
• W2104593712 sameAs 2104593712 @default.
• W2104593712 citedByCount "90" @default.
• W2104593712 countsByYear W21045937122012 @default.
• W2104593712 countsByYear W21045937122013 @default.
• W2104593712 countsByYear W21045937122014 @default.
• W2104593712 countsByYear W21045937122015 @default.
• W2104593712 countsByYear W21045937122016 @default.
• W2104593712 countsByYear W21045937122017 @default.
• W2104593712 countsByYear W21045937122018 @default.
• W2104593712 countsByYear W21045937122019 @default.
• W2104593712 countsByYear W21045937122021 @default.
• W2104593712 countsByYear W21045937122022 @default.
• W2104593712 countsByYear W21045937122023 @default.
• W2104593712 crossrefType "journal-article" @default.
• W2104593712 hasAuthorship W2104593712A5000460815 @default.
• W2104593712 hasAuthorship W2104593712A5006898867 @default.
• W2104593712 hasAuthorship W2104593712A5081779855 @default.
• W2104593712 hasAuthorship W2104593712A5085722983 @default.
• W2104593712 hasBestOaLocation W21045937121 @default.
• W2104593712 hasConcept C2776277131 @default.
• W2104593712 hasConcept C2778891214 @default.
• W2104593712 hasConcept C2781097354 @default.
• W2104593712 hasConcept C3019240266 @default.
• W2104593712 hasConcept C42219234 @default.
• W2104593712 hasConcept C71924100 @default.
• W2104593712 hasConceptScore W2104593712C2776277131 @default.
• W2104593712 hasConceptScore W2104593712C2778891214 @default.
• W2104593712 hasConceptScore W2104593712C2781097354 @default.
• W2104593712 hasConceptScore W2104593712C3019240266 @default.
• W2104593712 hasConceptScore W2104593712C42219234 @default.
• W2104593712 hasConceptScore W2104593712C71924100 @default.
• W2104593712 hasIssue "6" @default.
• W2104593712 hasLocation W21045937121 @default.
• W2104593712 hasLocation W21045937122 @default.
• W2104593712 hasOpenAccess W2104593712 @default.
• W2104593712 hasPrimaryLocation W21045937121 @default.
• W2104593712 hasRelatedWork W1033173965 @default.
• W2104593712 hasRelatedWork W1586706517 @default.
• W2104593712 hasRelatedWork W1645313311 @default.
• W2104593712 hasRelatedWork W1971834844 @default.
• W2104593712 hasRelatedWork W2349853116 @default.
• W2104593712 hasRelatedWork W2390399741 @default.
• W2104593712 hasRelatedWork W2393748027 @default.
• W2104593712 hasRelatedWork W2418634528 @default.
• W2104593712 hasRelatedWork W2475613734 @default.
• W2104593712 hasRelatedWork W3122913396 @default.
• W2104593712 hasVolume "91" @default.
• W2104593712 isParatext "false" @default.
• W2104593712 isRetracted "false" @default.
• W2104593712 magId "2104593712" @default.
• W2104593712 workType "article" @default.